Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natan Silva-Costa

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Psychopharmacology (Oxford, England)|December 4, 2025
Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillationsNatan Silva-Costa, Jéssica Andrade Pessoa, Kátia Cristina Andrade, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 23, 2023
Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trialMarcelo Falchi-Carvalho, Isabel Wießner, Sérgio Ruschi B Silva, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 18, 2025
Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trialIsabel Wießner, Marcelo Falchi-Carvalho, Sophie Laborde, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Psychopharmacology (Oxford, England)|December 4, 2025
Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillationsNatan Silva-Costa, Jéssica Andrade Pessoa, Kátia Cristina Andrade, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 23, 2023
Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trialMarcelo Falchi-Carvalho, Isabel Wießner, Sérgio Ruschi B Silva, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 18, 2025
Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trialIsabel Wießner, Marcelo Falchi-Carvalho, Sophie Laborde, et al.
Pageof 1